Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05784012
Title	Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma (RADIAN)
Acronym	RADIAN
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Grupo Espanol de Tratamiento de Tumores de Cabeza y Cuello
Indications	oral squamous cell carcinoma oropharynx cancer laryngeal squamous cell carcinoma hypopharynx cancer
Therapies	Dostarlimab-gxly + Niraparib Cisplatin + Dostarlimab-gxly + Niraparib
Age Groups:	adult \| senior
Covered Countries	ESP